{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:13:56Z","timestamp":1789902836267,"version":"4.0.1"},"reference-count":40,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Anterior myocardial infarction is a critical condition with significant implications for cardiac function and patient prognosis. Despite advancements in reperfusion therapies, optimizing recovery during the early phases of myocardial infarction remains challenging. Anterior myocardial infarction can lead to substantial long-term effects on a patient\u2019s health due to extensive damage to the heart muscle, particularly the left ventricle, impacting both quality of life and overall prognosis. Vericiguat, a soluble guanylate cyclase stimulator, has shown promise in heart failure, but its role in early anterior myocardial infarction has not yet been fully explored. By enhancing soluble guanylate cyclase activity, vericiguat may increase cyclic guanosine monophosphate production, leading to vasodilation, inhibition of platelet aggregation, and potential cardioprotective effects. Currently, treatment options for anterior myocardial infarction primarily focus on reperfusion strategies and managing complications. However, there is a critical need for adjunctive therapies that specifically target the pathophysiological changes occurring in the early phases of myocardial infarction. Vericiguat\u2019s mechanism of action offers a novel approach to improving vascular function and myocardial health, potentially contributing to innovative treatment strategies that could transform the care and prognosis of patients with anterior myocardial infarction.<\/jats:p>","DOI":"10.3390\/medicina60101595","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T04:00:04Z","timestamp":1727668804000},"page":"1595","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Vericiguat in Early Phases of Anterior Myocardial Infarction: A Potential Game-Changer?"],"prefix":"10.3390","volume":"60","author":[{"given":"Federico","family":"Cacciapuoti","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, \u201cL. Vanvitelli\u201d University, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Mauro","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u201cA. Cardarelli\u201d Hospital, Via A. Cardarelli, 6, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Capone","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u201cA. Cardarelli\u201d Hospital, Via A. Cardarelli, 6, 80131 Naples, Italy"},{"name":"Department of Advanced Biomedical Sciences, \u201cFederico II\u201d University, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Chianese","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u201cA. Cardarelli\u201d Hospital, Via A. Cardarelli, 6, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Gaetano","family":"Tarquinio","sequence":"additional","affiliation":[{"name":"Post-Graduate School of Emergency Medicine, \u201cL. Vanvitelli\u201d University, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Gottilla","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u201cA. Cardarelli\u201d Hospital, Via A. Cardarelli, 6, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Marsico","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u201cA. Cardarelli\u201d Hospital, Via A. Cardarelli, 6, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Crispo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u201cA. Cardarelli\u201d Hospital, Via A. Cardarelli, 6, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7687-6346","authenticated-orcid":false,"given":"Fulvio","family":"Cacciapuoti","sequence":"additional","affiliation":[{"name":"Division of Cardiology, \u201cA. Cardarelli\u201d Hospital, Via A. Cardarelli, 6, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.amjcard.2013.07.037","article-title":"Trends in myocardial infarction rates and case fatality by anatomical location in four United States communities, 1987 to 2008 (from the Atherosclerosis Risk in Communities Study)","volume":"112","author":"Newman","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_2","first-page":"e38","article-title":"Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association [published correction appears in Circulation","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yu, B., Akushevich, I., Yashkin, A.P., and Kravchenko, J. (2021). Epidemiology of Geographic Disparities of Myocardial Infarction Among Older Adults in the United States: Analysis of 2000\u20132017 Medicare Data. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.707102"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hlc.2017.10.023","article-title":"Predictors of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Complicated with Cardiogenic Shock","volume":"28","author":"Keskin","year":"2019","journal-title":"Heart Lung Circ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/ehjqcco\/qcaa037","article-title":"Door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty","volume":"7","author":"Karkabi","year":"2017","journal-title":"Eur. Heart J. Quality Care Clinic Outcomes"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","article-title":"2015 ACC\/AHA\/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction","volume":"67","author":"Levine","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MCA.0000000000001334","article-title":"The impact of the site of myocardial infarction on in-hospital outcomes for patients with STEMI","volume":"35","author":"Kwok","year":"2024","journal-title":"Coron. Artery Dis."},{"key":"ref_8","first-page":"14","article-title":"Predictors of fatal outcome in acute myocardial infarction","volume":"20","author":"Shabbir","year":"2009","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/ehjacc\/zuaa012","article-title":"Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: Insights from the high-risk myocardial infarction database","volume":"10","author":"Hui","year":"2021","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/cts.13677","article-title":"Vericiguat, a novel sGC stimulator: Mechanism of action, clinical, and translational science","volume":"16","author":"Trujillo","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-012-9323-1","article-title":"Soluble guanylate cyclase: A potential therapeutic target for heart failure","volume":"18","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. et Biophys. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.120.047086","article-title":"Comparing the Benefit of Novel Therapies Across Clinical Trials: Insights From the VICTORIA Trial","volume":"142","author":"Butler","year":"2020","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhu, W., Ben, Y., Shen, Y., and Liu, W. (2023). Vericiguat protects against cardiac damage in a pig model of ischemia\/reperfusion. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0295566"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"122184","DOI":"10.1016\/j.lfs.2023.122184","article-title":"Vericiguat alleviates ventricular remodeling and arrhythmias in mouse models of myocardial infarction via CaMKII signaling","volume":"334","author":"Chen","year":"2023","journal-title":"Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lavalle, C., Mariani, M.V., Severino, P., Palombi, M., Trivigno, S., D\u2019Amato, A., Silvetti, G., Pierucci, N., Di Lullo, L., and Chimenti, C. (2024). Efficacy of modern therapies for heart failure with reduced ejection fraction in specific population subgroups: A systematic review and network meta-analysis. Cardiorenal Med., 1\u201323.","DOI":"10.1159\/000541393"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.yjmcc.2008.07.015","article-title":"Nitric oxide signaling and the regulation of myocardial function","volume":"45","author":"Ziolo","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00395-016-0540-y","article-title":"Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: A systematic review of experimental and clinical studies","volume":"111","author":"Bice","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature12722","article-title":"Dysfunctional nitric oxide signalling increases risk of myocardial infarction","volume":"504","author":"Erdmann","year":"2013","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11010-009-0219-x","article-title":"Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart","volume":"333","author":"Umar","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Roman-Campos, D., Sales-Junior, P., Santos-Miranda, A., Joviano-Santos, J.V., Ropert, C., and Cruz, J.S. (2020). Deletion of inducible nitric oxide synthase delays the onset of cardiomyocyte electrical remodeling in experimental Chagas disease. Biochim. et Biophys. Acta (BBA) Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165949"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sahana, U., Wehland, M., Simonsen, U., Schulz, H., and Grimm, D. (2023). A Systematic Review of the Effect of Vericiguat on Patients with Heart Failure. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411826"},{"key":"ref_27","unstructured":"(2023). Vericiguat. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and Digestive and Kidney Diseases."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamacardio.2020.6455","article-title":"Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights from the VICTORIA Trial","volume":"6","author":"Lam","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/pnasnexus\/pgae225","article-title":"Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators","volume":"3","author":"Peddibhotla","year":"2024","journal-title":"PNAS Nexus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00395-018-0679-9","article-title":"cGMP at the centre of attention: Emerging strategies for activating the cardioprotective PKG pathway","volume":"113","author":"Park","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Borghi, C., Omboni, S., Reggiardo, G., Bacchelli, S., Degli Esposti, D., and Ambrosioni, E. (2018). Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: A meta-analysis of individual data of four randomized, double-blind, prospective studies. BMC Cardiovasc. Disord., 18.","DOI":"10.1186\/s12872-018-0800-x"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with \u03b2-blockers for myocardial infarction: A meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/CIRCINTERVENTIONS.121.010720","article-title":"The art of prescribing \u03b2-blockers after myocardial infarction","volume":"14","author":"Desta","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"New Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a Mediator of Cardiovascular Damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/17512433.2022.2121702","article-title":"Clinical pharmacology of antiplatelet drugs","volume":"15","author":"Gelbenegger","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2021.10.035","article-title":"Heart Failure Incidence Following ST-Elevation Myocardial Infarction","volume":"164","author":"Costa","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e009034","DOI":"10.1161\/CIRCINTERVENTIONS.120.009034","article-title":"Cardiogenic Shock in the Setting of Acute Myocardial Infarction History Repeating Itself?","volume":"13","author":"Elgendy","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/00033197221105753","article-title":"Evaluation of Intermountain Risk Score for Short- and Long-Term Mortality in ST Elevation Myocardial Infarction Patients","volume":"74","author":"Akbulut","year":"2023","journal-title":"Angiology"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1595\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:06:08Z","timestamp":1760112368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/10\/1595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["medicina60101595"],"URL":"https:\/\/doi.org\/10.3390\/medicina60101595","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]}}}